Optical controlled and nuclear targeted CECR2 competitor to downregulate CSF-1 for metastatic breast cancer immunotherapy

This study provides a promising therapeutic target and reliable strategy for metastatic breast cancer treatment by interrupting immunosuppressive crosstalk between tumor cells and macrophages.PMID:38615488 | DOI:10.1016/j.biomaterials.2024.122568

Source: Biomaterials - April 14, 2024 Category: Materials Science Authors: Yi Cen Ying Chen Xinxuan Li Xiayun Chen Baixue Yu Mengyi Yan Ni Yan Hong Cheng Shiying Li Source Type: research